CytoDyn Treats First Patient in Phase 1b/2 Clinical Trial with Leronlimab (PRO 140) for Patients with Treatment-Naïve, Metastatic Triple-Negative Breast Cancer

Stock Information for CytoDyn Inc

Loading

Please wait while we load your information from QuoteMedia.